Phase III trial results show that once-daily brensocatib reduces pulmonary exacerbations and slows lung function decline in patients with bronchiectasis.
The FDA approved Rinvoq (upadacitinib) as the first and only oral Janus kinase inhibitor for the treatment of giant cell arteritis in adults, providing a steroid-sparing option for achieving sustained remission.
“Approval of an immediate-use intranasal diazepam treatment that can be given at any time—even while a child is actively seizing—in this young age group is an important advance for the epilepsy community.”
The U.S. military conducted a propaganda campaign in the Philippines to discredit China's Sinovac vaccine and COVID aid, leading to a Senate investigation in the country.
'The strength of evidence of benefits to adult smokers from completely switching to a less harmful product was sufficient to outweigh the risks to youth.'
Nearly three months into the bird flu outbreak, U.S. testing is alarmingly low, raising concerns about undetected spread and preparedness for a potential pandemic.